期刊文献+

CRM197对豚鼠血脑屏障通透性的影响 被引量:2

Effect of CRM197 on the Permeability of Blood-Brain Barrier in Guinea Pigs
下载PDF
导出
摘要 目的研究白喉毒素的无毒突变体CRM197对豚鼠血脑屏障通透性的影响和作用机制。方法给予豚鼠不同浓度的CRM197后,采用伊文氏兰法检测血脑屏障通透性的变化;荧光显微镜观察给予示踪剂伊文氏兰和荧光素钠后血脑屏障完整性的改变;透射电镜观察血脑屏障中血管内皮细胞间紧密连接等结构的变化。结果随着给予CRM197浓度的增加,血脑屏障对伊文氏兰的通透性逐渐增大,其中100,300,500μg/kgCRM197剂量组血脑屏障的通透性显著高于对照组(P<0.01)。给予300μg/kgCRM197后30min,未见有伊文氏兰-白蛋白渗漏到脑血管外周。透射电镜观察,不同浓度的CRM197作用后30min血脑屏障的完整性无明显改变,随着CRM197浓度的增大,脑微血管内皮细胞中吞饮小泡的数量有一定程度的增加,未见紧密连接明显开放。结论CRM197以剂量依赖的方式增加血脑屏障的通透性,其机制主要与胞吞转运增加有关,血脑屏障的完整性不受影响。 Objective To investigate the effect and mechanism of cross-reacting material 197 (CRM197) on the permeability of blood-brain barrier (BBB) in guinea pigs. Methods After injecting the different concentrations of CRM 197, the changes of BBB permeability were measured by Evans blue (EB) assay and the integrity of BBB was observed by fluorescent microscope with the infusion of the tracers of EB and sodium fluorescein (NF). Transmission electron microscope (TEM) was used to observe the morphous of interendothelial tight junction of capillaries in BBB. Results With the increase of the concentrations of CRM197, the permeability of EB extravasation in BBB increased gradually. Compared with control group, the permeability of BBB increased significantly after treatment with CRM197 of 100, 300, 500 μg/kg (P〈0.01) 30 rain after the treatment of 300 μg/kg CRM197, no leakage of EB-albumin was found around perivascular area. The BBB remained integrated with different concentrations of CRM197 for 30 min under TEM,. With the increase of the concentrations of CRM197, the number of pinocytotic vesicles also rose to a higher level, however, no significant opening of tight junction was observed. Conclusion CRM 197 could increase the permeability of BBB in a dose-dependent manner and the increase of pinocytotic vesicles in microvessel endothelial cells might be the main mechanism, with the intergrity of BBB.
出处 《解剖科学进展》 CAS 2008年第4期416-419,共4页 Progress of Anatomical Sciences
基金 国家自然科学基金(No.30670723) 辽宁省自然科学基金(No.2008850) 沈阳市科学技术计划基金(No.1072033-1-00)
关键词 CRM197 血脑屏障 通透性 豚鼠 CRM197 blood-brain battier permeability guinea pig
  • 相关文献

参考文献10

  • 1Rennels MB, Edwards KM, Keyserling HL, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants[J]. Pediatrics, 1998, 101: 604- 611.
  • 2Buzzi S, Rubboli D, Buzzi G, et al. CRM197(nontoxic diphtheria toxin):effects on advanced cancer patients[J]. Cancer Immunol hnmunother, 2004, 53(11): 1041-1048.
  • 3Singh AB, Tsukada T, Zent R, et al. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells[J]. J Cell Sci, 2004, 117: 1365-1379.
  • 4Gaillard PJ, Visser CC and de Boer AG. Diphtheria toxin receptor- targeted brain drug delivery[J]. International Congress Series, 2005, 1277: 185-198.
  • 5汪薇,王诗航.光密度值测定在实验医学研究中的应用及意义[J].解剖科学进展,2006,12(3):286-286. 被引量:26
  • 6Blakeley J. Drug delivery to brain tumors[J]. Curr Neurol Neurosci Rep, 2008, 8(3): 235-241.
  • 7王萍,付伟,薛一雪.缓激肽持续作用对胶质瘤细胞内钙离子浓度的影响[J].解剖科学进展,2007,13(3):193-195. 被引量:4
  • 8Pardridge WM. Drug and gene targeting to the brain with molecular Trojan horses[J]. Nat Rev Drug Discov, 2002, 1(2): 131-139.
  • 9Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation[J]. Pharm Res, 2007, 24(9): 1759-1771.
  • 10Cohen KA, Liu TF, Cline JM, et al. Safety evaluation of DT388IL3, a diphtheria toxin/interleukin 3 fusion protein, in the eynomolgus monkey[J]. Cancer Immunol Immunother, 2005, 54(8): 799-806.

二级参考文献8

  • 1张振彪,刘云会,谷艳婷,薛一雪.ATP敏感性钾通道蛋白在缓激肽选择性开放血肿瘤屏障中的表达[J].解剖科学进展,2007,13(1):8-10. 被引量:1
  • 2Matsukado K,Inamura T,Nakano S,et al.Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog,RMP-7[J].Neurosurg,1996,39(1):125-134.
  • 3Nichloas G,Avgeropoulos,Tracy T,et al.New treatment strategies for malignant gliomas[J].Oncologist,1999,4(3):209-224.
  • 4Lee KM,Toscas K and Villereal ML.Inhibition of bradykinin-and thapsigargin-induced Ca^2+ entry by tyrosine kinase inhibitors[J].J Biol Chem,1993,268(14):9945-9948.
  • 5Lisanti MP,Scherer PE,Tang Z,et al.Oligomeric structure of caveolin:implications for caveolae membrane organization[J].Trends Cell Biol,1994,4(7):231-235.
  • 6Gutowski S,Smrcka A,Nowak L,et al.Antibodies to the alphaq subfamily of guanine nucleotide-binding regulatory protein alpha subunits attenuate activation of phosphatidylinositol 4,5-bisphosphate hydrolysis by hormones[J].J Biol Chem,1991,266(30):20519-20524.
  • 7Wilk-Blaszczak MA,Singer WD,and Belardetti F.Three distinct G protein pathways mediate inhibition of neuronal calcium current by bradykinin[J].J Neurophysiol,1996,76(5):3559-3562.
  • 8Ningaraj NS,Rao M,Hashizume K,et al.Regulation of bloodbrain barrier permeability by calcium-activated potassium channels[J].J Pharmacol Exp Ther,2002,301(3):838-851.

共引文献28

同被引文献26

  • 1Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegenera-tion [ J ]. Trends Neurosci, 2008,28 (4) :202.
  • 2Wu X, Lu Y, Dong Y, et al. The inhalation anesthetic isoflurane in- creases levels of proinflammatory TNF - a, IL - 6, and IL - 113 [ J ]. Neurobiol Aging,2012,33 (7) : 1364.
  • 3Song Y, Cui T, Xie N, et al. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged APP/PS1 double transgenic mice [ J ]. Int Immunophannacol, 2014,20 (1) :276.
  • 4Orr N,Galen JE,Levine MM.Expression and immunogenicity ofa mutant diphtheria toxin molecule,CRM197, and its fragmentsin Salmonella typhi vaccine strain CVD 908-htrA[J].Infect lmmun,1999,67(8):4290-4294.
  • 5Rappuoli R. Isolation and characterization of Corynebacteriumdiphtheriae nontandem double lysogens hyperproducingCRM197[J].Appl Environ Microbiol,1983,46(3):560-564.
  • 6李模孝,张薛,王栋海,等.白喉毒素突变体CRM197 及其制备方法[P].中国专利:100999548,2006-01-10.
  • 7Black S,Shinefield H,Fireman B,et a1.Efficacy,safety and immunogenicityof heptavalent pneumococcal conjugate vaccine inchildren[J].Pediatr Infect Dis J,2000,19(3):187-195.
  • 8Francesco B, Paolo C,Marco F,et al.Water accessibility,aggregation,and motional features of polysaccharide-proteinconjugate vaccines[J].Biophys J,2004,86(1):3-9.
  • 9Ajani JA,Randolph Heeht J,Ho L,et al. An open-label,multinational,multicenter study of G17DT vaccination combined withcisplatin and 5-fluorouracil in patients with untreated, advancedgastric or gastroesophageal cancer: the GC4 study[J].Cancer,2006,106(9):1908-1916.
  • 10Sticking P, Peyre M,Coombes L,et al.Transcutaneous immunizationwith cross-reacting material CRM197 of diphtheriatoxin boosts functional antibody levels in mice primed parenterallywith adsorbed diphtheria toxoid vaccine[J].Infect Immun,2008,76(4):1766-1773.

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部